Tin t&#x1EE9;c &amp; C&#x1EAD;p nh&#x1EAD;t

Exhaled breath analysis using the so-called eNose technology not only accurately identifies individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) but also pinpoints those at high risk of accelerated disease progression.

SGLT2 inhibitors lower stroke, mortality risks in AF patients with T2DM

Treatment with SGLT2 inhibitors appears to reduce the risks of stroke, dementia, long-standing persistent atrial fibrillation (AF), heart failure, and mortality in patients with both AF and type 2 diabetes mellitus (T2DM), suggests a recent study.

ADHD treatment helps prevent suicidal behaviours, accidents

Drug treatment for attention deficit/hyperactivity disorder (ADHD) may reduce the first occurrence rates of suicidal behaviours, substance misuse, transport accidents, and criminality, but not accidental injuries, suggest the results of a target trial emulation.

29 Aug 2025

Adalimumab vs cyclosporine: Which is better for dermatological symptoms in VKH disease?

Immunosuppression with prednisone plus either adalimumab or cyclosporine is effective in improving alopecia, but neither treatment does not provide any significant impact on the presence of vitiligo or poliosis in patients with Vogt-Koyanagi-Harada (VKH) disease at 6 months, reports a study.

No benefit to adding adjuvant chemo to hormonotherapy in high-risk breast cancer

Adding adjuvant chemotherapy to hormonotherapy does not appear to improve survival outcomes in older women with high-risk estrogen receptor (ER)-positive, HER2-negative breast cancer and is even associated with more adverse events, as shown in a phase III study.

Daridorexant benefits women with insomnia during menopausal transition

Treatment with daridorexant improved sleep outcomes and daytime functioning in women with insomnia disorder during the menopausal transition, according to a study presented at EAN 2025.

7,000 steps a day may be enough

Walking 7,000 steps a day can offer the same health benefits as walking 10,000 steps a day, according to a comprehensive review and meta-analysis. Experts said it could be a more realistic target than the 10,000 steps, which is traditionally seen as the benchmark to reach.

Steroidal mineralocorticoid receptor antagonist offers no CV mortality benefit in dialysis patients

Treatment with steroidal mineralocorticoid receptor antagonists does not appear to provide significant protection against cardiovascular mortality in patients undergoing dialysis, as shown in a systematic review and meta-analysis.

Mild behavioural impairment a warning signal for neurodegeneration

28 Aug 2025 bởi

People who report symptoms of mild behavioural impairment exhibit pronounced cortical thinning in regions involved in emotion regulation, belief formation, and cognitive control in the right side of the brain, according to a study.

Rituximab not superior to conventional therapy in EGPA

The use of rituximab falls short of demonstrating superiority over a conventional remission induction strategy in patients diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA), reveals a study.